Publicacións en colaboración con investigadores/as de University of Copenhagen (15)

2022

  1. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Kidney International, Vol. 101, Núm. 1, pp. 174-184

  2. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

    Biological Psychiatry, Vol. 91, Núm. 1, pp. 102-117

2021

  1. A polygenic resilience score moderates the genetic risk for schizophrenia

    Molecular Psychiatry, Vol. 26, Núm. 3, pp. 800-815

  2. Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial

    European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227

2020

  1. Complement genes contribute sex-biased vulnerability in diverse disorders

    Nature, Vol. 582, Núm. 7813, pp. 577-581

2019

  1. Gene expression imputation across multiple brain regions provides insights into schizophrenia risk

    Nature Genetics, Vol. 51, Núm. 4, pp. 659-674

  2. Publisher Correction: Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection (Nature Genetics, (2018), 50, 3, (381-389), 10.1038/s41588-018-0059-2)

    Nature Genetics

  3. Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (Nature Genetics, (2019), 51, 4, (659-674), 10.1038/s41588-019-0364-4)

    Nature Genetics

2018

  1. Age at first birth in women is genetically associated with increased risk of schizophrenia

    Scientific Reports, Vol. 8, Núm. 1

  2. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

    Nature Genetics, Vol. 50, Núm. 3, pp. 381-389

2017

  1. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Nature Genetics, Vol. 49, Núm. 1, pp. 27-35

  2. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

    Nature Communications, Vol. 8

2015

  1. LD score regression distinguishes confounding from polygenicity in genome-wide association studies

    Nature Genetics, Vol. 47, Núm. 3, pp. 291-295

2014

  1. Biological insights from 108 schizophrenia-associated genetic loci

    Nature, Vol. 511, Núm. 7510, pp. 421-427

2013

  1. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

    New England Journal of Medicine, Vol. 369, Núm. 26, pp. 2492-2503